RA Capital Management led a $40.75m Series A round in NanoMosaic.

RA Capital Management, an investment advisor specializing in the life-sciences and drug development sectors, led a $40.75m Series A round in NanoMosaic, a biotechnology company, with participation from Insight Partners, Pura Vida Investments, Time BioVentures and Tiger Gene. "NanoMosaic places the future of proteomics in the hands of scientists: fully configurable, simple to run and ripe for additional application development. We are proud to partner with a world-class technical team to help expand access to this powerful platform," Anurag Kondapalli, RA Capital Principal.